Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Dr. Falk Pharma GmbH"
Count: 44
Selected: 0
| NCT ID | Title |
|---|
| NCT05083390 | Norursodeoxycholic Acid vs. Placebo in NASH | ||
| NCT05488405 | Mesalazine Oral Suspension in Active Eosinophilic Esophagitis | ||
| NCT05621811 | Different Doses of Naronapride vs. Placebo in Gastroparesis | ||
| NCT05305599 | Different Doses of ZED1227 vs. Placebo in NAFLD | ||
| NCT02493335 | Maintenance of Remission With Budesonide Orodispersible Tablets vs. Placebo in Eosinophilic Esophagitis | ||
| NCT02142634 | Budesonide for Induction of Remission in Incomplete Microscopic Colitis | ||
| NCT00746486 | Ursodeoxycholic Acid Plus Budesonide Versus Ursodeoxycholic Acid Alone in Primary Biliary Cirrhosis (PBC) | ||
| NCT02280629 | Phosphatidylcholine (LT-02) vs. Placebo vs. Mesalamine for Maintenance of Remission in Ulcerative Colitis (PROTECT-2) | ||
| NCT03872921 | norUrsodeoxycholic Acid vs Placebo in PSC | ||
| NCT01966783 | Budesonide vs. Mesalazine vs. Budesonide/Mesalazine Suppository Combination Therapy in Acute Ulcerative Proctitis | ||
| NCT01510860 | Ursofalk Tablets (500 mg) Versus Ursofalk Capsules (250 mg) in the Treatment of Primary Biliary Cirrhosis | ||
| NCT00838214 | Budesonide 3x3mg/d Versus Prednisone in Active Autoimmune Hepatitis | ||
| NCT00529009 | Pharmacokinetic Investigation of UDCA in Bile and Serum | ||
| NCT01208922 | Rifamycin SV-MMX® Tablets Versus Ciprofloxacin Capsules in Acute Traveller's Diarrhoea | ||
| NCT02550418 | Budesonide 9 mg Capsules in Active UC | ||
| NCT01847664 | Rifamycin SV-MMX® 400 mg b.i.d. vs. Rifamycin SV-MMX® 600 mg t.i.d. vs. Placebo in Acute Uncomplicated Diverticulitis | ||
| NCT01209208 | Budesonide Versus Mesalazine Versus Placebo in Lymphocytic Colitis | ||
| NCT00695643 | Mesalazine Granules vs. Placebo for the Prevention of Recurrence of Diverticulitis | ||
| NCT01038739 | Two Doses Mesalazine Granules Versus Placebo for the Prevention of Recurrence of Diverticulitis | ||
| NCT02142725 | Phosphatidylcholine (LT-02) for Induction of Remission in Ulcerative Colitis | ||
| NCT02434029 | Budesonide Orodispersible Tablet vs. Placebo in Active Eosinophilic Esophagitis | ||
| NCT01755507 | Norursodeoxycholic Acid in the Treatment of Primary Sclerosing Cholangitis | ||
| NCT01745770 | TID 1000 mg Mesalazine Versus TID 2x500 mg Mesalazine in Active Ulcerative Colitis (UC) | ||
| NCT02280616 | Budesonide Effervescent Tablets vs. Viscous Budesonide Suspension vs. Placebo in Eosinophilic Esophagitis | ||
| NCT01627262 | Mesalamine for Uncomplicated Diverticular Disease: a Randomized, Double-blind, Placebo-controlled Study | ||
| NCT01278082 | SOIBD Collagenous Colitis Maintenance Study | ||
| NCT00887263 | Efficacy and Safety Study of Budesonide to Treat Oral Chronic Graft vs Host Disease (cGvHD) | ||
| NCT00449722 | OD vs. TID Dosing With Mesalazine Granules in Active Ulcerative Colitis | ||
| NCT01279577 | Trichuris Suis Ova (TSO) Suspension Versus Placebo in Active Crohn's Disease | ||
| NCT01086553 | 9 mg Budesonide Once Daily (OD) Versus 3 mg Budesonide Three Times Daily (TID) in Active Crohn's Disease | ||
| NCT00450086 | Budesonide Capsules vs. Mesalazine Granules vs. Placebo in Collagenous Colitis | ||
| NCT00300118 | Oral Budesonide vs. Oral Mesalazine in Active Crohn's Disease (CD) | ||
| NCT00946946 | Preventing Postoperative Relapse in Crohn's Disease Patients at Risk: Azathioprine Versus Mesalazine | ||
| NCT00747110 | Budesonide Capsules Versus Mesalazine Granules in Active Ulcerative Colitis (UC) | ||
| NCT00746447 | Once Daily (OD) Versus Three Times Daily (TID) Dosing With Mesalazine Granules for Prevention of Recurrence of Ulcerative Colitis (UC) | ||
| NCT00828230 | Budesonide Foam Versus Placebo for Prevention of Acute Radiation Proctitis | ||
| NCT03844932 | A Study Evaluating the Efficacy and Safety of ST-0529 in Subjects With Moderately to Severely Active Ulcerative Colitis | ||
| NCT01882088 | Phase IV Study of the Impact of Dietary Fibers on Symptoms and Esophageal Motility in Patients With Non-erosive GERD | ||
| NCT00180089 | Budesonide for Prevention of Acute Gastrointestinal GVHD Following Allogenic Stem Cell Transplantation | ||
| NCT00180050 | Budesonide Treatment for Lymphocytic Colitis | ||
| NCT00285597 | Ursodeoxycholic Acid in Chronic Heart Failure | ||
| NCT00128739 | Treatment of Gastro-Intestinal and/or Hepatic Graft Versus Host Disease With Budesonide in Patients Following Peripheral Blood Stem Cell Transplantation | ||
| NCT00338910 | Pharmacokinetic Interaction Study Between Budesonide and Metronidazole in Healthy Volunteers | ||
| NCT00161083 | UDCA for Symptomatic Gallstone Disease |
